www.fdanews.com/articles/139834-roche-to-pay-evotec-10-million-for-right-to-experimental-alzheimer-rsquo-s-drug

Roche to Pay Evotec $10 Million for Right to Experimental Alzheimer’s Drug

September 6, 2011

Roche Holding will pay Evotec $10 million for the right to develop Evotec’s EVT 302 compound for Alzheimer’s disease.
Bloomberg